3554 results for «2215»

Filter By

3554 results

Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024

17 May 2024 – From EuroPCR 2024

Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.

References

  • SOLVE-TAVI: Feistritzer HJ, et al....
EuroPCR 2024 Scientific highlights, clinical trial updates and key learnings

TAVI outcomes outside the cathlab – Importance of haemodynamics and durability

23 May 2019 – From EuroPCR 2019

Watch this LIVE case to learn more on TAVI in failed surgical aortic bioprosthesis, how to minimise risk of patient-prosthesis mismatch and coronary protection.

A 91-year-old female with an active lifestyle underwent a surgical aortic valve replacement 15 years ago. She presents with NYHA III and CCS...

TAVI outcomes outside the cathlab – Importance of haemodynamics and durability

Management of dislodged TAVI valves

22 May 2019 – From EuroPCR 2019

Consult this session to learn through various compelling clinical cases how to efficiently manage dislodged TAVI valves, and discover various tools and techniques to do so.

Management of dislodged TAVI valves

TAVI for aortic valve-in-valve - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...

TAVI for aortic valve-in-valve

TAVI for a patient with severe aortic stenosis and a mechanical mitral prosthesis - Session with LIVE case

18 Nov 2019 – From PCR London Valves 2019

View this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAVI for a patient with

Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to appreciate the critical importance of the Heart Team in identifying the optimal treatment strategy for patients with mitral and tricuspid valve disease, and to learn more about the challenges of transcatheter mitral and tricuspid valve interventions and the complexities associated with patient and device...

Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?

Challenging scenarios in acute coronary syndrome

20 May 2025 – From EuroPCR 2025

This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.

Challenging scenarios in acute coronary syndrome

Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS

21 May 2025 – From EuroPCR 2025

Unlock cutting-edge strategies for thrombus removal in acute coronary syndrome (ACS) with this EuroPCR 2025 session. Understand the mechanisms behind microvascular obstruction and no-reflow phenomena, and why effective thrombus management is crucial. Review the latest clinical evidence, from the Cheetah study to the ongoing TACTIC randomised...

Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

DCB in de novo lesions: new valid option?

20 May 2025 – From EuroPCR 2025

Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.

DCB in de novo lesions: new valid option?

Key principles of successful large bore vascular access and closure: TAVI and beyond

21 May 2025 – From EuroPCR 2025

This session explores suture-mediated vascular closure techniques, particularly for TAVI and large-bore venous access.  

Through real-world clinical case, speakers highlight the value of ultrasound and CT imaging for precise puncture planning and complication avoidance.  

Detailed steps for arterial closure with ProGlide device are provided, with technical...

Key principles of successful large bore vascular access and closure: TAVI and beyond

TMVR in challenging scenarios

20 May 2025 – From EuroPCR 2025

Navigate the challenges of transcatheter mitral valve replacement (TMVR) in complex clinical scenarios. This session explores treatment options when clipping is not feasible in a patient with heart failure and severe MR, management of multivalvular disease, advanced septal crossing techniques, and strategies for non-surgical candidates ineligible...

TMVR in challenging scenarios

Why should laser atherectomy be part of your complex PCI algorithm?

21 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...

Why should laser atherectomy be part of your complex PCI algorithm?

How to manage coronary artery disease in TAVI candidates?

20 May 2025 – From EuroPCR 2025

Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.

How to manage coronary artery disease in TAVI candidates?

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

Role of imaging in ACS: from non-invasive to invasive investigations

20 May 2025 – From EuroPCR 2025

Explore the critical role of imaging in acute coronary syndrome (ACS) from non-invasive coronary CT angiography to invasive intracoronary imaging modalities. This session covers detection of culprit lesions, diagnostic strategies, and PCI optimization through real-world case examples.

Role of imaging in ACS: from non-invasive to invasive investigations

Mitral hotline: new devices

20 May 2025 – From EuroPCR 2025

Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...

Mitral hotline: new devices

Getting started with a renal denervation programme

20 May 2025 – From EuroPCR 2025

Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.

Getting started with a renal denervation programme

TAVI in patients with a small annulus

20 May 2025 – From EuroPCR 2025

Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.

TAVI in patients with a small annulus

New evidence for treatment of calcified coronary artery disease

20 May 2025 – From EuroPCR 2025

Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...

New evidence for treatment of calcified coronary artery disease
Didn’t find what you were looking for?